COVISTA INC (CVSA) Fundamental Analysis & Valuation

NYSE:CVSA • US00737L1035

Current stock price

115.25 USD
+1.22 (+1.07%)
At close:
115.25 USD
0 (0%)
After Hours:

This CVSA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CVSA Profitability Analysis

1.1 Basic Checks

  • CVSA had positive earnings in the past year.
  • In the past year CVSA had a positive cash flow from operations.
  • In the past 5 years CVSA has always been profitable.
  • Each year in the past 5 years CVSA had a positive operating cash flow.
CVSA Yearly Net Income VS EBIT VS OCF VS FCFCVSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • The Return On Assets of CVSA (9.69%) is better than 82.19% of its industry peers.
  • The Return On Equity of CVSA (18.37%) is better than 83.56% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.77%, CVSA belongs to the best of the industry, outperforming 89.04% of the companies in the same industry.
  • CVSA had an Average Return On Invested Capital over the past 3 years of 9.63%. This is significantly below the industry average of 15.17%.
  • The 3 year average ROIC (9.63%) for CVSA is below the current ROIC(13.77%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.69%
ROE 18.37%
ROIC 13.77%
ROA(3y)5.64%
ROA(5y)5.9%
ROE(3y)10.98%
ROE(5y)11.83%
ROIC(3y)9.63%
ROIC(5y)7.66%
CVSA Yearly ROA, ROE, ROICCVSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

1.3 Margins

  • CVSA has a Profit Margin of 13.41%. This is amongst the best in the industry. CVSA outperforms 84.93% of its industry peers.
  • In the last couple of years the Profit Margin of CVSA has declined.
  • CVSA's Operating Margin of 19.55% is amongst the best of the industry. CVSA outperforms 82.19% of its industry peers.
  • CVSA's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 57.38%, CVSA is doing good in the industry, outperforming 72.60% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CVSA has remained more or less at the same level.
Industry RankSector Rank
OM 19.55%
PM (TTM) 13.41%
GM 57.38%
OM growth 3Y19.65%
OM growth 5Y4.08%
PM growth 3Y-16.17%
PM growth 5YN/A
GM growth 3Y2.86%
GM growth 5Y1.26%
CVSA Yearly Profit, Operating, Gross MarginsCVSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. CVSA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CVSA is creating some value.
  • CVSA has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, CVSA has less shares outstanding
  • Compared to 1 year ago, CVSA has an improved debt to assets ratio.
CVSA Yearly Shares OutstandingCVSA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CVSA Yearly Total Debt VS Total AssetsCVSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • CVSA has an Altman-Z score of 4.60. This indicates that CVSA is financially healthy and has little risk of bankruptcy at the moment.
  • CVSA has a better Altman-Z score (4.60) than 82.19% of its industry peers.
  • The Debt to FCF ratio of CVSA is 1.37, which is an excellent value as it means it would take CVSA, only 1.37 years of fcf income to pay off all of its debts.
  • CVSA has a Debt to FCF ratio of 1.37. This is amongst the best in the industry. CVSA outperforms 83.56% of its industry peers.
  • CVSA has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
  • CVSA has a Debt to Equity ratio (0.37) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.37
Altman-Z 4.6
ROIC/WACC1.56
WACC8.83%
CVSA Yearly LT Debt VS Equity VS FCFCVSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • CVSA has a Current Ratio of 0.68. This is a bad value and indicates that CVSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of CVSA (0.68) is worse than 75.34% of its industry peers.
  • CVSA has a Quick Ratio of 0.68. This is a bad value and indicates that CVSA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.68, CVSA is not doing good in the industry: 73.97% of the companies in the same industry are doing better.
  • CVSA does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.68
CVSA Yearly Current Assets VS Current LiabilitesCVSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. CVSA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 29.98% over the past year.
  • CVSA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.77% yearly.
  • Looking at the last year, CVSA shows a quite strong growth in Revenue. The Revenue has grown by 11.92% in the last year.
  • The Revenue has been growing by 11.19% on average over the past years. This is quite good.
EPS 1Y (TTM)29.98%
EPS 3Y23.46%
EPS 5Y23.77%
EPS Q2Q%34.25%
Revenue 1Y (TTM)11.92%
Revenue growth 3Y8.97%
Revenue growth 5Y11.19%
Sales Q2Q%12.43%

3.2 Future

  • Based on estimates for the next years, CVSA will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.34% on average per year.
  • Based on estimates for the next years, CVSA will show a quite strong growth in Revenue. The Revenue will grow by 8.33% on average per year.
EPS Next Y20.63%
EPS Next 2Y17.2%
EPS Next 3Y17.34%
EPS Next 5YN/A
Revenue Next Year8.63%
Revenue Next 2Y7.62%
Revenue Next 3Y7.99%
Revenue Next 5Y8.33%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CVSA Yearly Revenue VS EstimatesCVSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
CVSA Yearly EPS VS EstimatesCVSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

7

4. CVSA Valuation Analysis

4.1 Price/Earnings Ratio

  • CVSA is valuated correctly with a Price/Earnings ratio of 14.85.
  • Compared to the rest of the industry, the Price/Earnings ratio of CVSA indicates a somewhat cheap valuation: CVSA is cheaper than 69.86% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.35. CVSA is valued slightly cheaper when compared to this.
  • With a Price/Forward Earnings ratio of 12.56, CVSA is valued correctly.
  • Based on the Price/Forward Earnings ratio, CVSA is valued cheaper than 82.19% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CVSA to the average of the S&P500 Index (22.61), we can say CVSA is valued slightly cheaper.
Industry RankSector Rank
PE 14.85
Fwd PE 12.56
CVSA Price Earnings VS Forward Price EarningsCVSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 68.49% of the companies in the same industry are more expensive than CVSA, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CVSA is valued cheaper than 84.93% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.81
EV/EBITDA 10.38
CVSA Per share dataCVSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CVSA has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CVSA's earnings are expected to grow with 17.34% in the coming years.
PEG (NY)0.72
PEG (5Y)0.62
EPS Next 2Y17.2%
EPS Next 3Y17.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CVSA Dividend Analysis

5.1 Amount

  • CVSA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CVSA Fundamentals: All Metrics, Ratios and Statistics

COVISTA INC

NYSE:CVSA (3/31/2026, 8:27:51 PM)

After market: 115.25 0 (0%)

115.25

+1.22 (+1.07%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-28
Earnings (Next)05-06
Inst Owners102.79%
Inst Owner ChangeN/A
Ins Owners1.45%
Ins Owner Change10.46%
Market Cap3.98B
Revenue(TTM)1.89B
Net Income(TTM)253.25M
Analysts88
Price Target164.22 (42.49%)
Short Float %5.29%
Short Ratio5.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.83%
Min EPS beat(2)8.76%
Max EPS beat(2)8.91%
EPS beat(4)4
Avg EPS beat(4)9.44%
Min EPS beat(4)6.2%
Max EPS beat(4)13.91%
EPS beat(8)8
Avg EPS beat(8)13.85%
EPS beat(12)12
Avg EPS beat(12)14.37%
EPS beat(16)16
Avg EPS beat(16)13.93%
Revenue beat(2)2
Avg Revenue beat(2)0.59%
Min Revenue beat(2)0.2%
Max Revenue beat(2)0.98%
Revenue beat(4)4
Avg Revenue beat(4)1.27%
Min Revenue beat(4)0.2%
Max Revenue beat(4)2.26%
Revenue beat(8)8
Avg Revenue beat(8)1.79%
Revenue beat(12)12
Avg Revenue beat(12)1.77%
Revenue beat(16)14
Avg Revenue beat(16)7.41%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)-4.26%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.97%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.85
Fwd PE 12.56
P/S 2.11
P/FCF 10.81
P/OCF 9.29
P/B 2.88
P/tB N/A
EV/EBITDA 10.38
EPS(TTM)7.76
EY6.73%
EPS(NY)9.17
Fwd EY7.96%
FCF(TTM)10.66
FCFY9.25%
OCF(TTM)12.4
OCFY10.76%
SpS54.73
BVpS39.95
TBVpS-9.92
PEG (NY)0.72
PEG (5Y)0.62
Graham Number83.52
Profitability
Industry RankSector Rank
ROA 9.69%
ROE 18.37%
ROCE 17%
ROIC 13.77%
ROICexc 14.13%
ROICexgc 75.81%
OM 19.55%
PM (TTM) 13.41%
GM 57.38%
FCFM 19.48%
ROA(3y)5.64%
ROA(5y)5.9%
ROE(3y)10.98%
ROE(5y)11.83%
ROIC(3y)9.63%
ROIC(5y)7.66%
ROICexc(3y)10.68%
ROICexc(5y)8.65%
ROICexgc(3y)69.89%
ROICexgc(5y)49.9%
ROCE(3y)11.9%
ROCE(5y)9.46%
ROICexgc growth 3Y43.58%
ROICexgc growth 5Y21.13%
ROICexc growth 3Y34.8%
ROICexc growth 5Y6.87%
OM growth 3Y19.65%
OM growth 5Y4.08%
PM growth 3Y-16.17%
PM growth 5YN/A
GM growth 3Y2.86%
GM growth 5Y1.26%
F-Score8
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 1.37
Debt/EBITDA 1.19
Cap/Depr 112.6%
Cap/Sales 3.17%
Interest Coverage 250
Cash Conversion 101.29%
Profit Quality 145.32%
Current Ratio 0.68
Quick Ratio 0.68
Altman-Z 4.6
F-Score8
WACC8.83%
ROIC/WACC1.56
Cap/Depr(3y)65.95%
Cap/Depr(5y)64.36%
Cap/Sales(3y)2.82%
Cap/Sales(5y)3.22%
Profit Quality(3y)159.84%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.98%
EPS 3Y23.46%
EPS 5Y23.77%
EPS Q2Q%34.25%
EPS Next Y20.63%
EPS Next 2Y17.2%
EPS Next 3Y17.34%
EPS Next 5YN/A
Revenue 1Y (TTM)11.92%
Revenue growth 3Y8.97%
Revenue growth 5Y11.19%
Sales Q2Q%12.43%
Revenue Next Year8.63%
Revenue Next 2Y7.62%
Revenue Next 3Y7.99%
Revenue Next 5Y8.33%
EBIT growth 1Y11.93%
EBIT growth 3Y30.39%
EBIT growth 5Y15.73%
EBIT Next Year38.69%
EBIT Next 3Y18.01%
EBIT Next 5YN/A
FCF growth 1Y87.3%
FCF growth 3YN/A
FCF growth 5Y35.23%
OCF growth 1Y68.41%
OCF growth 3Y217.06%
OCF growth 5Y25.69%

COVISTA INC / CVSA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of COVISTA INC (CVSA) stock?

ChartMill assigns a fundamental rating of 7 / 10 to CVSA.


Can you provide the valuation status for COVISTA INC?

ChartMill assigns a valuation rating of 7 / 10 to COVISTA INC (CVSA). This can be considered as Undervalued.


How profitable is COVISTA INC (CVSA) stock?

COVISTA INC (CVSA) has a profitability rating of 8 / 10.


What is the earnings growth outlook for COVISTA INC?

The Earnings per Share (EPS) of COVISTA INC (CVSA) is expected to grow by 20.63% in the next year.


Is the dividend of COVISTA INC sustainable?

The dividend rating of COVISTA INC (CVSA) is 0 / 10 and the dividend payout ratio is 0%.